Folate receptor-targeted near-infrared photodynamic therapy for folate receptor-overexpressing tumors

doi:10.5306/wjco.v13.i11.880

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4499)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-9) series.

Item

Count

PDF

211

WORD

HTML

1777

Figures (1-9)

259

Sum=2300

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

209

Download

873

Sum=1082

Publishing Process of This Article

Item

Count

Browse

307

Download

810

Sum=1117

Nov 24, 2022 (publication date) through Nov 19, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Clin Oncol. Nov 24, 2022; 13(11): 880-895
Published online Nov 24, 2022. doi: 10.5306/wjco.v13.i11.880

Full Size Figure Download Figure

Figure 6 Experimental treatment scheme. Tumor bearing mice were assigned to four groups: A: folate-Si-rhodamine-1 injection alone; B: Near-infrared (NIR) photodynamic therapy (50 J/cm²); C: NIR irradiation alone (50 J/cm²); and D: no treatment. FolateSiR-1: Folate-Si-rhodamine-1; NIR-PDT: Near-infrared photodynamic therapy; IR: Laser irradiation; CTR: Control; wt: Weight; vol: Volume.

Citation: Aung W, Tsuji AB, Hanaoka K, Higashi T. Folate receptor-targeted near-infrared photodynamic therapy for folate receptor-overexpressing tumors. World J Clin Oncol 2022; 13(11): 880-895
URL: https://www.wjgnet.com/2218-4333/full/v13/i11/880.htm
DOI: https://dx.doi.org/10.5306/wjco.v13.i11.880